North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Impact of Multiple NAb Tests Compared to Usual Care of MS Patients on High-dose IFN Therapy
- Study Title
- Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy
- Teva Identifier
- PM028
- ClinicalTrials.gov Identifier
- NCT00336557
- Study Status
- Completed
- Trial Condition(s)
- Multiple Sclerosis
- Interventions
- Procedure: NAbs testing
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 07/01/2006 - 07/01/2009
